A senior brand director with Novartis Oncology since August of 2019, Nadia Al-Aydi oversees commercialization efforts for the renal cell carcinoma and soft tissue sarcoma product brand Votrient. She previously served 2 years as director of strategy and operations for the Novartis Oncology US Solid Tumor Franchise, leading the organization to a Breast Cancer Franchise Excellence Award in 2018. All told, Nadia Al-Aydi has worked for Novartis for nearly a decade, joining the organization in 2010 as an area sales manager with the Novartis Cardiovascular Division.

Before joining the Novartis team, Ms. Al-Aydi served a year as a regional director with DynaVox Technologies, and 16 years as a sales and marketing professional with Pfizer Pharmaceuticals. Over the course of her career, she has regularly attended the industry events of organizations such as the American Society of Clinical Oncology, the European Society for Medical Oncology, the American Society of Hematology, and the European Hematology Association.